We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,306
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRTY icon
7376
ProShares UltraPro Short Russell2000
SRTY
$73M
$8K ﹤0.01%
4
-58
-94% -$123K
STRT icon
7377
STRATTEC Security
STRT
$372M
$8K ﹤0.01%
+340
New +$7.42K
TBX icon
7378
ProShares Short 7-10 Year Treasury
TBX
$20.8M
$8K ﹤0.01%
293
+193
+193% +$5.09K
TIGR
7379
UP Fintech Holding
TIGR
$860M
$8K ﹤0.01%
2,199
+1,432
+187% +$5.42K
TTNP
7380
DELISTED
Titan Pharmaceuticals
TTNP
$8K ﹤0.01%
71
+69
+3,450% +$8.31K
UNL icon
7381
United States 12 Month Natural Gas Fund
UNL
$13.3M
$8K ﹤0.01%
907
-492
-35% -$4.33K
UONEK icon
7382
Urban One Class D
UONEK
$24.8M
$8K ﹤0.01%
+429
New +$8.76K
VNRX icon
7383
VolitionRx Ltd
VNRX
$9.58M
$8K ﹤0.01%
83
-143
-63% -$14.8K
VUZI icon
7384
Vuzix
VUZI
$213M
$8K ﹤0.01%
3,779
-1,128
-23% -$2.55K
YJ
7385
Yunji
YJ
$6.3M
$8K ﹤0.01%
45
-13
-22% -$2.69K
GVP
7386
DELISTED
GSE Systems, Inc.
GVP
$8K ﹤0.01%
465
-250
-35% -$3.43K
NURO
7387
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
$8K ﹤0.01%
220
-155
-41% -$4.49K
ACGN
7388
DELISTED
Aceragen Inc
ACGN
$8K ﹤0.01%
269
-139
-34% -$5.17K
BLU
7389
DELISTED
BELLUS Health Inc.
BLU
$8K ﹤0.01%
992
-983
-50% -$6.72K
PBDM
7390
DELISTED
Invesco PureBeta FTSE Developed ex-North America ETF
PBDM
$8K ﹤0.01%
329
-115
-26% -$2.82K
JJA
7391
DELISTED
iPath Series B Bloomberg Agriculture Subindex Total ReturnSM ETN
JJA
$8K ﹤0.01%
498
+21
+4% +$304
FUE
7392
DELISTED
ELEMENTS Linked to the ICE BofAML Commodity Index eXtra Biofuels Total Return
FUE
$8K ﹤0.01%
1,390
RIVE
7393
DELISTED
Riverview Financial Corporation Common Stock
RIVE
$8K ﹤0.01%
640
-1,605
-71% -$18.8K
GIX.U
7394
DELISTED
GigCapital2, Inc.
GIX.U
$8K ﹤0.01%
742
SMTX
7395
DELISTED
SMTC Corporation
SMTX
$8K ﹤0.01%
+2,355
New +$6.37K
NEOS
7396
DELISTED
Neos Therapeutics, Inc
NEOS
$8K ﹤0.01%
5,047
+3,045
+152% +$4.57K
HCCHU
7397
DELISTED
HL Acquisitions Corp. Unit
HCCHU
$8K ﹤0.01%
750
UGBP
7398
DELISTED
Exchange-Traded Notes linked to the VelocityShares Daily 4X Long GBP vs. USD Index due December 6, 2
UGBP
$8K ﹤0.01%
+410
New +$7.35K
PACQU
7399
DELISTED
Pure Acquisition Corp. Unit
PACQU
$8K ﹤0.01%
+800
New +$8.61K
TTPH
7400
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$8K ﹤0.01%
2,900
+336
+13% +$1.08K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.